Page 41 - Early Access Program News Today

COMPANY NEWS: First-of-its-kind solution for Managed Service Providers provides added security, protection, and streamlined recovery of critical...

/PRNewswire/ -- SINGAPORE patients with an aggressive form of lung cancer (metastatic small cell lung cancer) can now access a new therapy that may improve...

The program, with limited space, is available to all types of companies that want to test Square's services prior to general availability Square services include point-of-sale software and hardware

BrainChip has received the first batch of Akida AI chips from its manufacturing run from Socionext America (SNA). The chips were manufactured at TSMC from

BrainChip, a provider of ultra-low power high performance artificial intelligence technology, has announced that it has received the first batch of Akida chips from its manufacturing run from Socionext America (SNA).

OCALA, Fla., Aug. 17, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) announces financial results for the second quarter ended June 30, 2021 and provides a business update. Second

Looks to be still figuring out what to do with it, rather than prepping product Copy VMware has offered its customers the chance to use its flagship ESXi hypervisor running on SmartNICs. The virtualization giant yesterday announced an "Early Access Program" for Project Monterey – the effort to run ESXi on network accelerators and treat the devices as just another host that can run virtual machines and be managed by vSphere and vCenter. Plenty of network accelerators – a term The Register u...

iTWire Thursday, 15 July 2021 09:52 Bitdefender launches eXtended EDR to eliminate threats and attacks Shares Bitdefender launches eXtended EDR (XEDR), an endpoint detection and response solution that identifies and stops ransomware attacks. The solution is intended for organisations of all sizes. Bitdefender unveils the next generation of endpoint detection and response solutions—eXtended EDR with the addition of analytics and cross-endpoint security event correlation to Bitde...

board=Pharmaceutical&u=tlexander [ 1 ] 标  题: arimoclomol被FDA据了，当年这个也算很热门的，靶向HSP70 发信站: BBS 未名空间站 (Wed Jun 30 19:12:03 2021, 美东) Orphazyme A/S (ORPHA.CO), a biopharmaceutical company pioneering Heat-Shock Protein response for the treatment of neurodegenerative orphan diseases, today announces the availability of an Early Access Program (EAP) in the United States (US) for its investigational drug arimoclomol for the treatment of Niem...

Vertica announced early access of its new unified analytics-as-a-service offering, Vertica Eon Accelerator, delivering analytics at top speed from start to finish. Available via the Early Access Program, Vertica Eon Accelerator delivers the high-performance and scalable analytics as well as end-to-end, in-database machine learning to organizations that require the right level of resourcing, management, and control for each analytical use case – all built on the proven cloud native archite...